We have shown m k e d increases in t h e p l m amino acid concentrations of very lm birth weiqht (VIEW) infants treated with dexamethasone (Arch Dis Child 1992; 67: 5-9). ornithine, c i t n i t l i n e , alanine an3 glutamine increased mt. W e rn report rates of urinary excretion ~ethcds: 24-hour urine collections i n 6 VGW infants before ard a f t e r 48 hours of dexamthasone (0.6 n q kg-1 d-1). min no a c i d s were Conclusion: Increased excretion of both t h e end p m c t ard i n m a t e cconpounds of t h e urea cycle suppx+t t h e suggestion t h a t charges i n plasma amino acid concentrations result from catabolism r a t h e r than inhibition of nitmgen disposal. A new, still to be improved, neonatal phototherapy (PT) device -BiliblanketTM (BB), Ohmeda, USA -has been developed in the form of a fiber optic system, whose radically different method of application, directly to the baby's skin, implies some decrease in the usual PT side-effects (insensible water loss, birth weight decrement) and less physical and psychological stress to the jaundiced neonate. To compare its efficiency to conventional PT, 208 healthy preterm infants presenting non-haemolytic hyperbilirubinemia in the first four days of life -with no statistically difference in gestational age, birth weight, age and bilirub~n (BR) levels at onset of P)T -were subdivided at random in four study groups receiving respectively fiber optic (BB) PT. Special Blue (SB), White (DA) and Green (G) e t e r S A S c l e n t e c h . U S A ) Even though fiber optic PT showed significantly lower efficacy during the 24 hrs of PT compared to all (p<.001) but DA fluorescent lamps, after 24 hrs fiber optic light source and fluorescent I m p s showed similar efticiency (p>.5). Lithocholic acid (LCA) is a hepatotoxic compound. Fetal LCA might play a role in the pathogenesis of neonatal cholestasis/EHBk Recent results show that fetal liver has capacity for hydroxylations of LCA (Ped. Res. 21:99, 1987).
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METABOLISM AND NUTRITION
If the pathogenesis of EHBA involves increased fetal levels of LCA, the condition could be due to impaired fetal liver metabolism of LCA. This should lead to increased levels of LCA at birth.
LCA, cholic acid (CA) and chenodeoxycholic acid (CDCA) were quantitated in stored dried blood from six newborn infants with EHBA and fourteen controls. The blood was collected at neonatal metabolic screening. The bile acids were quantitated by gas chromatography-mass spectrometry using selected ion monitoring.
Results: Mean blood levels ( t S D ) of LCA were 0.11?0.10 r M in the infants with EHBA and 0.08?0.06 ILM in the controls. Mean blood levels ( t S D ) of CA and CDCA were 15.628.7 &M and 7.4+6.1 pM in the El-IBA infants and 1.7t1.2 FM and 1.821.5 &M in the controls.
Conclusion: The low blood levels of LCA found indicate a normal metabolism of this bile acid in fetuses with EHBA. The increased levels of CA and CDCA in the infants with this disease can be due to cholestasis. Urinary metabolites and 13C02-production from 13C-octanoic acid were studied in 12 patients (3-19 y.0.) with seizure disorders before and during valproic acid (VPA) therapy without and with L-camitine supplementation. Only one patient had a decreased plasma level of free camitine (FC) during VPA. Urinary FC concentrations were positively correlated with serum VPA levels (p<0.01) indicating a dose-related effect of VPA on the tubular reabsorption of FC. Urinary dicarboxylic acid concentrations relative to plasma p-01-I-butyrate and urinary hexanoyl-and butyrylglycine concentrations (stable isotope dilution method) increased during VPA. Changes in cumulative excretion of '3C02 in bruth were Inconslslent L-i.im~t~ns ;idrn1nisu3tion h.~d no signifiL..int effect. I 1/12 nntlcntt c~;rtted ~~tanovlcam~t~ne lOC\ in excess of oclenovlcnm~t~nc d u " n g '~~~. Quantitation of b~ by radidisoiopic e x c h a n g e l~~~6 showed urinary concenn-~tions of OC compmble to those found in asymptomatic patients with medium chain acyl-CoA dehydrogenase (MCAD) deficiency (x 0.7 1; R 0.09-14.6 vs. x 0.38; R 0.10-4.21 mmoles/mole creatinine). Gas chromatogr;~phic/niass spectrometric analysis revealed that the predominant s:lturated 8-carbon acylcmitine in urine w;~s OC with v~lproylcllrnitine king only a minor metabolite. Conclusion: VPA therapy results in an inhibition of Poxidation pllnly at the level of MCAD. L-camitine has no consistent effect.
CHANGES O F BODY COMPOSITION M CHILDREN FOLLOWING RENAL TRANSPLANTATION (TX)
. Franz Schaefer, Babette Hake, Rotraut Schulte, Karl Scharer. Children's Hospital, Heidelberg University, F.R.G.
We have recently demonstrated the validity of bioelectrical impedance (BI) analysis for assessing body composition in healthy and diseased children (Ped Res 29:350A). In order to study the effects of renal Tx and corticosteroid treatment on the body composition of childrenwith chronic renal failure, we followed up 15 patients aged 3.2 to 18.5 (mean 11.4) years for the first 12 months after Tx. Measurements of height, weight and BI were taken at 2, 4.6 and 8 weeks, and 3, 4, 6, 8, 10 and 12 months after Tx. Fat-free mass (FFM) was estimated from BI, according to a formula derived from previous validation studies using "K plethysmography as reference standard. An age-and sex-independent analysis was achieved by transformation of the raw data to standard deviation scores (SDS) based on regional standards for height, weight and body composition. To allow for the non-Gaussian distribution of weight and fat mass (FM), separate SD values were calculated for subjects above and below the 50th percentile.
Average relative height was subnormal (-1.94 + 1.8 SDS) and did not change during the first year after Tx. Relative weight for height increased during the first three months from -0.32 + 1.0 to t0.42 + 1.0 SDS (p<0.02), and changed only slightly thereafter. In contrast, relative FFM for height continued to increase from month 3 (-0.66 t. 0. ' ) SDS) to month 12 (+0.65 + 1.2 SDS, p<0.01).
Our study demonstrates that during the first 3 months after Tx. when high corticosteroid doses are applied, weight gain is mainly due to an expansion of the FM. Subsequently, the anabolic effect of restored renal function becomes apparent by a marked increase of FFM.
